Literature DB >> 25351497

Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance.

Alfio Ferlito1, Alessandra Rinaldo2, Justin A Bishop3, Jennifer L Hunt4, Vincent Vander Poorten5, Michelle D Williams6, Asterios Triantafyllou7, Kenneth O Devaney8, Douglas R Gnepp9, Kimihide Kusafuka10, Gyorgy B Halmos11, William H Westra3, Robert P Takes12, Lester D R Thompson13.   

Abstract

Paraneoplastic syndromes are associated with a variety of malignant neoplasms and are systemic and non-metastatic manifestations that develop in a minority of cancer patients. This review examines all published cases of paraneoplastic syndromes associated with neuroendocrine carcinomas of the larynx. There are a total of ten patients reported with paraneoplastic syndromes associated with laryngeal neuroendocrine carcinomas in the literature. Of these, nine died and the tenth is alive with liver metastases. There were five cases of small-cell neuroendocrine carcinoma, four cases of moderately differentiated neuroendocrine carcinoma, and one case of well-differentiated neuroendocrine carcinoma associated with paraneoplastic syndromes. As these syndromes have significant clinical relevance, physicians should be aware of the possible presence of paraneoplastic syndromes in the diagnostic process of patients with neuroendocrine carcinoma of the larynx.

Entities:  

Keywords:  Diagnosis; Larynx; Neuroendocrine carcinomas; Paraneoplastic syndromes; Prognosis

Mesh:

Year:  2014        PMID: 25351497     DOI: 10.1007/s00405-014-3351-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

1.  Small cell carcinoma of the larynx and ectopic antidiuretic hormone secretion.

Authors:  T J Myers; N Kessimian
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

2.  Large cell neuroendocrine carcinoma of the head and neck: a distinct clinicopathologic entity.

Authors:  Alfio Ferlito; Primož Strojan; James S Lewis; Bayardo Perez-Ordoñez; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-15       Impact factor: 2.503

3.  N-type calcium channel antibody-mediated paraneoplastic limbic encephalitis: a diagnostic challenge.

Authors:  Carlos Kamiya-Matsuoka; David Blas-Boria; Michelle D Williams; Pedro Garciarena; Sudhakar Tummala; Ivo W Tremont-Lukats
Journal:  J Neurol Sci       Date:  2014-01-09       Impact factor: 3.181

4.  Oat cell carcinoma of the larynx and Eaton-Lambert syndrome.

Authors:  J E Medina; M Moran; H Goepfert
Journal:  Arch Otolaryngol       Date:  1984-02

5.  Sinonasal neuroendocrine carcinoma in association with SIADH.

Authors:  Nilesh R Vasan; Jesus E Medina; Vikki A Canfield; Elizabeth M Gillies
Journal:  Head Neck       Date:  2004-01       Impact factor: 3.147

6.  Carcinoid (neuroendocrine carcinoma) of the larynx.

Authors:  R F Baugh; G T Wolf; R V Lloyd; K D McClatchey; D A Evans
Journal:  Ann Otol Rhinol Laryngol       Date:  1987 May-Jun       Impact factor: 1.547

7.  Multiple hormone production in an oat cell carcinoma of the larynx.

Authors:  J W Bishop; R Y Osamura; Y Tsutsumi
Journal:  Acta Pathol Jpn       Date:  1985-07

Review 8.  Bone marrow metastases from small cell cancer of the head and neck.

Authors:  S T Pierce; M L Cibull; M S Metcalfe; D Sloan
Journal:  Head Neck       Date:  1994 May-Jun       Impact factor: 3.147

Review 9.  Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.

Authors:  Tom P van der Laan; Boudewijn E C Plaat; Bernard F A M van der Laan; Gyorgy B Halmos
Journal:  Head Neck       Date:  2014-06-18       Impact factor: 3.147

Review 10.  Paraneoplastic syndromes in patients with primary head and neck cancer.

Authors:  Alfio Ferlito; Mohamed N Elsheikh; Johannes J Manni; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-01-06       Impact factor: 3.236

View more
  5 in total

Review 1.  Development of head and neck pathology in Europe.

Authors:  Henrik Hellquist; Abbas Agaimy; Göran Stenman; Alessandro Franchi; Alfons Nadal; Alena Skalova; Ilmo Leivo; Nina Zidar; Roderick H W Simpson; Pieter J Slootweg; Juan C Hernandez-Prera; Alfio Ferlito
Journal:  Virchows Arch       Date:  2022-01-14       Impact factor: 4.064

Review 2.  Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation?

Authors:  Andrés Coca-Pelaz; Kenneth O Devaney; Juan P Rodrigo; Gyorgy B Halmos; Primož Strojan; William M Mendenhall; Avraham Eisbruch; Robert Smee; Kimihide Kusafuka; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-03       Impact factor: 2.503

Review 3.  Paraneoplastic Syndromes Associated with Laryngeal Cancer.

Authors:  Alessandra Rinaldo; Andrés Coca-Pelaz; Carl E Silver; Alfio Ferlito
Journal:  Adv Ther       Date:  2019-12-04       Impact factor: 3.845

4.  Poorly Differentiated Neuroendocrine Larynx Carcinoma: Clinical Features and miRNAs Signature-A New Goal for Early Diagnosis and Therapy?

Authors:  Filippo Ricciardiello; Michela Falco; Giuseppe Tortoriello; Ferdinando Riccardi; Raul Pellini; Brigida Iorio; Giuseppe Russo; Giuseppe Longo; Ciro Coppola; Takashi Takeuchi; Anna Grimaldi; Marianna Abate; Marianna Scrima; Alessia Maria Cossu; Raffaele Addeo; Alessandro Ottaiano; Alfonso Scarpa; Amedeo Boscaino; Giovanni Motta; Michele Caraglia; Marco Bocchetti; Gabriella Misso
Journal:  J Clin Med       Date:  2021-05-08       Impact factor: 4.241

Review 5.  Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature.

Authors:  Tiziana Feola; Giulia Puliani; Franz Sesti; Roberta Modica; Marco Biffoni; Cira Di Gioia; Raffaella Carletti; Emanuela Anastasi; Valentina Di Vito; Roberta Centello; Andrea Lenzi; Andrea M Isidori; Antongiulio Faggiano; Elisa Giannetta
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-16       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.